ketoconazole has been researched along with Histoplasmosis in 113 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Histoplasmosis: Infection resulting from exposure to the fungus HISTOPLASMA. It is worldwide in distribution and particularly common in the central and eastern states, especially areas around the Ohio and Mississippi River valleys.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and safety of itraconazole in preventing relapse of histoplasmosis after induction therapy with amphotericin B in patients with the acquired immunodeficiency syndrome (AIDS) and disseminated histoplasmosis." | 9.07 | Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. ( Briggs, N; Connolly-Stringfield, P; Hafner, R; Hamill, R; Murphy, R; Owens, S; Powderly, W; Rinaldi, M; Saag, M; Spencer, P; Squires, K; Wheat, J; Wong, B; Wulfsohn, M, 1993) |
| "Itraconazole is a highly effective therapy for nonmeningeal, nonlife-threatening blastomycosis and histoplasmosis." | 9.07 | Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. ( Bowles-Patton, C; Bradsher, RW; Chapman, SW; Cloud, GC; Dismukes, WE; George, RB; Girard, WM; Kauffman, CA; Saag, MS; Stevens, DA, 1992) |
| "A non-comparative open trial with itraconazole in progressive forms of human histoplasmosis was carried out." | 9.06 | Itraconazole in human histoplasmosis. ( Arechavala, A; Negroni, R; Robles, AM; Taborda, A, 1989) |
| "In a multicenter prospective randomized trial, the efficacy and toxicity of low-dose (400 mg/d) and high-dose (800 mg/d) oral ketoconazole were compared in 80 patients with blastomycosis and in 54 with histoplasmosis." | 9.05 | Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. National Institute of Allergy and Infectious Diseases Mycoses Study Group. ( , 1985) |
| "A patient with African form of histoplasmosis was treated for 7 years with ketoconazole, with no response; after a 9-month daily treatment with 100 mg of itraconazole the patient was successfully cured." | 7.70 | African histoplasmosis: therapeutic efficacy of itraconazole. ( Cabral, JM; Massa, A; Velho, GC, 1998) |
| " Histoplasmosis complement fixation titers have been used to detect unsuspected subacute disease and to follow the therapeutic adjunctive management with ketoconazole, an oral antifungal agent." | 7.68 | Sclerosing mediastinitis: improved management with histoplasmosis titer and ketoconazole. ( Chung, SY; Disiere, J; Netto, GJ; Razzuk, MA; Urschel, HC, 1990) |
| "We have reported the first case of successful treatment of disseminated histoplasmosis in a renal allograft recipient using a short course (14 days) of amphotericin B in combination with prolonged therapy (161 days) with ketoconazole." | 7.67 | Combined ketoconazole and amphotericin B treatment of acute disseminated histoplasmosis in a renal allograft recipient. ( Goetz, MB; Jones, JM, 1985) |
| "Fluconazole was compared with ketoconazole and with amphotericin B in treatment of pulmonary histoplasmosis in immunologically intact mice and in congenitally athymic nude mice." | 7.67 | Treatment of murine histoplasmosis with UK 49,858 (fluconazole). ( Ahrens, J; Graybill, JR; Palou, E, 1986) |
| "Ketoconazole appears to be a safe drug in the treatment of chronic cavitary histoplasmosis." | 7.67 | Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole. ( Gorin, AB; Hamill, RJ; Musher, DM; Quinones, CA; Reuben, AG; Sarosi, GA, 1989) |
| "Four patients with disseminated histoplasmosis, two of whom had late relapses after previous therapy with amphotericin B, were treated with ketoconazole 200 to 400 mg daily for 1 year." | 7.66 | Progressive disseminated histoplasmosis; favorable response to ketoconazole. ( Alford, RH; Gregory, DW; Hawkins, SS, 1981) |
| "Five patients received ketoconazole treatment of chronic mucocutaneous candidiasis." | 7.66 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Graybill, JR; Herndon, JH; Kniker, WT; Levine, HB, 1980) |
| "Ten patients with disseminated histoplasmosis and seven with progressive cavitary histoplasmosis were treated with ketoconazole, an imidazole derivative that is well absorbed orally and relatively nontoxic." | 7.66 | Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole. ( Slama, TG, 1983) |
| "A 46-year-old man with recurrent pulmonary histoplasmosis was given oral treatment with ketoconazole (a new imidazole derivative related to miconazole) in a dose of 400 mg/day for 3 months, followed by 200 mg daily for 6 months." | 7.66 | [Oral ketoconazole therapy of a case of pulmonary histoplasmosis]. ( Zellweger, JP, 1981) |
| "Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 7.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
| "Treatment with amphotericin B combined with ketoconazole was successful." | 6.40 | African histoplasmosis: report of two patients treated with amphotericin B and ketoconazole. ( Akpuaka, FC; Gugnani, HC; Iregbulam, LM, 1998) |
| "A patient with AIDS presented with a fever, shortness of breath and a productive cough." | 5.28 | Disseminated histoplasmosis in an AIDS patient treated with itraconazole. ( Barton, SE; Gazzard, BG; Kell, PD; Midgley, J; Samarasinghe, PL; Smith, DE, 1991) |
| " Review of these five cases and 31 additional relapsing cases from the literature indicates that fungal endocarditis or endarteritis without surgical treatment, underlying lymphoreticular neoplasm, and amphotericin B dosage of less than 2 g appear to be associated with relapse of PDH." | 5.26 | Conditions associated with relapse of amphotericin B-treated disseminated histoplasmosis. ( Alford, RH; Bradsher, RW; Hawkins, SS; Spickard, WA, 1982) |
| "To assess the efficacy and safety of itraconazole in preventing relapse of histoplasmosis after induction therapy with amphotericin B in patients with the acquired immunodeficiency syndrome (AIDS) and disseminated histoplasmosis." | 5.07 | Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. ( Briggs, N; Connolly-Stringfield, P; Hafner, R; Hamill, R; Murphy, R; Owens, S; Powderly, W; Rinaldi, M; Saag, M; Spencer, P; Squires, K; Wheat, J; Wong, B; Wulfsohn, M, 1993) |
| "Itraconazole is a highly effective therapy for nonmeningeal, nonlife-threatening blastomycosis and histoplasmosis." | 5.07 | Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. ( Bowles-Patton, C; Bradsher, RW; Chapman, SW; Cloud, GC; Dismukes, WE; George, RB; Girard, WM; Kauffman, CA; Saag, MS; Stevens, DA, 1992) |
| "A non-comparative open trial with itraconazole in progressive forms of human histoplasmosis was carried out." | 5.06 | Itraconazole in human histoplasmosis. ( Arechavala, A; Negroni, R; Robles, AM; Taborda, A, 1989) |
| "In a multicenter prospective randomized trial, the efficacy and toxicity of low-dose (400 mg/d) and high-dose (800 mg/d) oral ketoconazole were compared in 80 patients with blastomycosis and in 54 with histoplasmosis." | 5.05 | Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. National Institute of Allergy and Infectious Diseases Mycoses Study Group. ( , 1985) |
| "Prior to the development of ketoconazole, the treatment of systemic histoplasmosis and blastomycosis was limited to AMB." | 4.77 | Treatment of histoplasmosis and blastomycosis. ( Dismukes, WE; Saag, MS, 1988) |
| "A patient with African form of histoplasmosis was treated for 7 years with ketoconazole, with no response; after a 9-month daily treatment with 100 mg of itraconazole the patient was successfully cured." | 3.70 | African histoplasmosis: therapeutic efficacy of itraconazole. ( Cabral, JM; Massa, A; Velho, GC, 1998) |
| "From 1983 through 1996 all infants with documented disseminated histoplasmosis were treated with amphotericin B followed by daily ketoconazole for 3 months." | 3.70 | Disseminated histoplasmosis in infants. ( Carranza, A; Carrillo, JM; Mora, L; Navarrete, M; Odio, CM, 1999) |
| "A 49-year-old man with disseminated histoplasmosis (pulmonary and central nervous system involvement) successfully treated with ketoconazole and fluconazole combination is reported." | 3.70 | [Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection]. ( Astoul, P; Bérard, H; Boutin, C; Cho, K; Cuguillière, A; Frenay, C, 1999) |
| "A 46-year-old homosexual man with disseminated histoplasmosis and human immunodeficiency virus (HIV) infection had a histoplasmosis-related ulcerated verrucous plaque above his left upper lip; systemic and cutaneous disease manifestations of histoplasmosis resolved with daily ketoconazole therapy." | 3.68 | Disseminated histoplasmosis presenting as an ulcerated verrucous plaque in a human immunodeficiency virus-infected man. Report of a case possibly involving human-to-human transmission of histoplasmosis. ( Cohen, PR; Grossman, ME; Held, JL; Ross, MJ; Silvers, DN, 1991) |
| " Histoplasmosis complement fixation titers have been used to detect unsuspected subacute disease and to follow the therapeutic adjunctive management with ketoconazole, an oral antifungal agent." | 3.68 | Sclerosing mediastinitis: improved management with histoplasmosis titer and ketoconazole. ( Chung, SY; Disiere, J; Netto, GJ; Razzuk, MA; Urschel, HC, 1990) |
| "Two patients with fungal infection of the central nervous system (coccidioidal meningitis and cerebral histoplasmomas) were treated with ketoconazole for 30 months." | 3.67 | Treatment of central nervous system fungal infection with ketoconazole. ( Barnett, AM; Goodpasture, HC; Hershberger, RE; Peterie, JD, 1985) |
| "A comparative study between itraconazole, ketoconazole and amphotericin B in the treatment of experimental histoplasmosis in hamsters was carried out." | 3.67 | Treatment of disseminated histoplasmosis in hamsters. ( Bava, AJ; Finquelievich, JL; Iovannitti, C; Negroni, R, 1989) |
| "Ketoconazole appears to be a safe drug in the treatment of chronic cavitary histoplasmosis." | 3.67 | Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole. ( Gorin, AB; Hamill, RJ; Musher, DM; Quinones, CA; Reuben, AG; Sarosi, GA, 1989) |
| "Fluconazole was compared with ketoconazole and with amphotericin B in treatment of pulmonary histoplasmosis in immunologically intact mice and in congenitally athymic nude mice." | 3.67 | Treatment of murine histoplasmosis with UK 49,858 (fluconazole). ( Ahrens, J; Graybill, JR; Palou, E, 1986) |
| "We have reported the first case of successful treatment of disseminated histoplasmosis in a renal allograft recipient using a short course (14 days) of amphotericin B in combination with prolonged therapy (161 days) with ketoconazole." | 3.67 | Combined ketoconazole and amphotericin B treatment of acute disseminated histoplasmosis in a renal allograft recipient. ( Goetz, MB; Jones, JM, 1985) |
| "Five patients received ketoconazole treatment of chronic mucocutaneous candidiasis." | 3.66 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Graybill, JR; Herndon, JH; Kniker, WT; Levine, HB, 1980) |
| "A 46-year-old man with recurrent pulmonary histoplasmosis was given oral treatment with ketoconazole (a new imidazole derivative related to miconazole) in a dose of 400 mg/day for 3 months, followed by 200 mg daily for 6 months." | 3.66 | [Oral ketoconazole therapy of a case of pulmonary histoplasmosis]. ( Zellweger, JP, 1981) |
| "Four patients with disseminated histoplasmosis, two of whom had late relapses after previous therapy with amphotericin B, were treated with ketoconazole 200 to 400 mg daily for 1 year." | 3.66 | Progressive disseminated histoplasmosis; favorable response to ketoconazole. ( Alford, RH; Gregory, DW; Hawkins, SS, 1981) |
| "We treated 29 patients with ketoconazole for systemic mycoses." | 3.66 | Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens. ( Craven, PC; Donovan, W; Graybill, JR; Matthew, EB, 1982) |
| "Ten patients with disseminated histoplasmosis and seven with progressive cavitary histoplasmosis were treated with ketoconazole, an imidazole derivative that is well absorbed orally and relatively nontoxic." | 3.66 | Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole. ( Slama, TG, 1983) |
| "Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 3.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
| "Ketoconazole, an oral, broad-spectrum antifungal agent with relatively low toxicity, is the preferred drug for treatment of chronic mucocutaneous candidiasis and an alternative choice for treatment of thrush, vaginitis, histoplasmosis, and coccidioidomycosis." | 3.66 | Oral antifungal therapy. Current status of ketoconazole. ( Varkey, B, 1983) |
| "To our knowledge, histoplasmosis has not been previously reported in Cushing's disease, and has rarely been reported in patients with exogenous glucocorticoid use." | 2.44 | Nodular pulmonary histoplasmosis in Cushing's disease: a case report and literature review. ( Jordan, RM; Kosseifi, SG; Nassour, DN; Peiris, AN; Sarubbi, FA; Shaikh, MA, 2007) |
| "American pulmonary histoplasmosis is a deep mycosis imported from North America caused by the inhalation of Histoplasma capsulatum." | 2.40 | [American pulmonary histoplasmosis caused by Histoplasma capsulatum]. ( Bonnet, D; Cuguillière, A; Guigay, J; Jancovici, R; L'Her, P; Le Vagueresse, R; Lonjon, T; Miltgen, J; Natali, E; Vaylet, F, 1998) |
| "Treatment with amphotericin B combined with ketoconazole was successful." | 2.40 | African histoplasmosis: report of two patients treated with amphotericin B and ketoconazole. ( Akpuaka, FC; Gugnani, HC; Iregbulam, LM, 1998) |
| "Histoplasmosis has become an important mycosis in regions of endemicity in North and Central America." | 2.39 | Histoplasmosis: recognition and treatment. ( Wheat, J, 1994) |
| "Histoplasmosis has emerged as the leading opportunistic infection in patients with AIDS from Indianapolis." | 2.38 | Histoplasmosis in Indianapolis. ( Wheat, LJ, 1992) |
| "The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
| "Mycotic pneumonias are common problems seen in small companion animals because of the wide environmental distribution of fungi and their use of airborne spores for reproduction." | 2.37 | Mycotic pneumonias. ( Roudebush, P, 1985) |
| "Radiography and CT scan revealed a spondylodiscitis without any bone reconstruction in both cases and a prevertebral abscess in one case." | 1.31 | [Spondylodiscitis due to Histoplasma duboisii. Report of two cases and review of the literature]. ( Ba Zeze, V; Broalet, E; Kakou, M; N'dri Oka, D; Varlet, G; Zunon-Kipre, Y, 2001) |
| "Histoplasmosis is an important cause of morbidity and death in HIV-infected patients." | 1.30 | Histoplasmosis: update 1998. ( Brooks, JT; Wheat, LJ, 1998) |
| "Histoplasmosis is a fungal infection caused by the organism Histoplasma capsulatum." | 1.29 | Oral histoplasmosis in HIV-infected patients. A report of two cases. ( Chernoff, DN; Chinn, H; Green, TL; Migliorati, CA; Silverman, S, 1995) |
| "Data is summarized on six patients with allergic bronchopulmonary aspergillosis, all of whom improved on therapy, and twelve patients with histoplasmosis including eight with AIDS, eleven of whom responded (three newly reported cases are included)." | 1.28 | [The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States]. ( Hostetler, JS; Stevens, DA, 1991) |
| "Data are summarized on 6 patients with allergic bronchopulmonary aspergillosis, 5 of whom demonstrated marked improvement on therapy, and 12 patients with histoplasmosis including 8 with AIDS, 11 of whom responded and 1 recrudesced on therapy." | 1.28 | US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host. ( Denning, DW; Hostetler, JS; Stevens, DA, 1992) |
| "The substantial early mortality of AIDS-associated disseminated histoplasmosis and the modestly encouraging survival of those who were diagnosed in time to receive adequate therapy raise the issues of surveillance, prophylaxis, and empiric therapy for this infection in selected HIV-positive patients." | 1.28 | Disseminated histoplasmosis in patients with AIDS. ( Burns, DK; Hernandez, JA; Nightingale, SD; Parks, JM; Pounders, SM; Reynolds, J, 1990) |
| "Treatment with ketoconazole was initially successful." | 1.28 | Histoplasmosis in the acquired immunodeficiency syndrome (AIDS). ( Gardner, FJ; MacLeod, C; Packham, DR; Rawlinson, WD, 1989) |
| "Ketoconazole alone was ineffective in the majority of cases." | 1.28 | Clinical review: progressive disseminated histoplasmosis in the AIDS patient. ( Hamill, RJ; Johnson, PC; Sarosi, GA, 1989) |
| "The results in histoplasmosis are encouraging, as are the results in chromomycosis, particularly those cases associated with Cladosporium carrionii." | 1.28 | Tropical mycoses. ( Bayles, MA, 1992) |
| "A patient with AIDS presented with a fever, shortness of breath and a productive cough." | 1.28 | Disseminated histoplasmosis in an AIDS patient treated with itraconazole. ( Barton, SE; Gazzard, BG; Kell, PD; Midgley, J; Samarasinghe, PL; Smith, DE, 1991) |
| "The results in histoplasmosis are encouraging as are the results in chromomycosis particularly those cases associated with C." | 1.28 | [Tropical mycoses]. ( Bayles, MA, 1991) |
| "Acute histoplasmosis is an infrequently recognized pulmonary disease endemic in Puerto Rico." | 1.28 | Acute histoplasmosis: a modern appraisal. ( Ramírez Rivera, J, 1989) |
| "Amphotericin B was effective in all patients receiving at least 500 mg, but relapse occurred if the total dose was less than 30 mg/kg." | 1.27 | Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. ( Batteiger, BE; Sathapatayavongs, B; Slama, TG; Wass, JL; Wheat, J, 1983) |
| "Intraoral histoplasmosis is difficult to diagnose, both because the clinician fails to be aware of it and because the lesion has clinical similarities to other disease entities, creating a misleading clinical impression." | 1.27 | Oral histoplasmosis: diagnostic complication and treatment. ( Frame, RR; Toth, BB, 1983) |
| "Three patients with Histoplasma capsulatum infections of abdominal aortic aneurysms are reported." | 1.27 | Histoplasma infection of abdominal aortic aneurysms. ( Alford, RH; Dean, RH; Hawkins, SS; Miller, BM; Smith, BM; Waterhouse, G, 1983) |
| "The ongoing epidemic of acquired immune deficiency syndrome (AIDS) has affected homosexual men, intravenous (IV) drug abusers, Haitians, hemophiliacs, and others." | 1.27 | Disseminated histoplasmosis in patients with the acquired immune deficiency syndrome. ( Alexander, WJ; App, W; Bonner, JR; Dismukes, WE; Griffin, FM; Little, R; Shin, MS, 1984) |
| "Previous review articles of AIDS have failed to mention this infection." | 1.27 | Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. ( Butt, F; Johnson, PC; Khardori, N; Mansell, PW; Najjar, AF; Sarosi, GA, 1988) |
| "Four of five had the acquired immune deficiency syndrome (AIDS) and one was receiving steroid therapy." | 1.27 | Histoplasmosis in patients with the acquired immune deficiency syndrome. ( Goldberg, DM; Mandell, W; Neu, HC, 1986) |
| "Disseminated histoplasmosis is a major opportunistic infection in patients with AIDS from endemic areas." | 1.27 | Histoplasmosis in the acquired immune deficiency syndrome. ( Slama, TG; Wheat, LJ; Zeckel, ML, 1985) |
| " Review of these five cases and 31 additional relapsing cases from the literature indicates that fungal endocarditis or endarteritis without surgical treatment, underlying lymphoreticular neoplasm, and amphotericin B dosage of less than 2 g appear to be associated with relapse of PDH." | 1.26 | Conditions associated with relapse of amphotericin B-treated disseminated histoplasmosis. ( Alford, RH; Bradsher, RW; Hawkins, SS; Spickard, WA, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (51.33) | 18.7374 |
| 1990's | 50 (44.25) | 18.2507 |
| 2000's | 4 (3.54) | 29.6817 |
| 2010's | 1 (0.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marchiori, E | 1 |
| Melo, SMD | 1 |
| Vianna, FG | 1 |
| Melo, BSD | 1 |
| Melo, SSD | 1 |
| Zanetti, G | 1 |
| Kosseifi, SG | 1 |
| Nassour, DN | 1 |
| Shaikh, MA | 1 |
| Sarubbi, FA | 1 |
| Jordan, RM | 1 |
| Peiris, AN | 1 |
| Goldfarb, J | 1 |
| Hilton, E | 1 |
| Sperling, R | 1 |
| Baum, SG | 1 |
| Nieto, RD | 1 |
| Miranda, E | 1 |
| Ermocilla, R | 1 |
| Sáenz, R | 1 |
| Díaz, R | 1 |
| Hughes, WT | 1 |
| Bonner, JR | 1 |
| Alexander, WJ | 1 |
| Dismukes, WE | 5 |
| App, W | 1 |
| Griffin, FM | 1 |
| Little, R | 1 |
| Shin, MS | 1 |
| Graybill, JR | 4 |
| Herndon, JH | 1 |
| Kniker, WT | 1 |
| Levine, HB | 1 |
| Check, WA | 1 |
| Zellweger, JP | 1 |
| Hawkins, SS | 3 |
| Gregory, DW | 1 |
| Alford, RH | 3 |
| Bradsher, RW | 2 |
| Spickard, WA | 1 |
| Chretien, JH | 1 |
| Garagusi, VF | 1 |
| Craven, PC | 1 |
| Donovan, W | 1 |
| Matthew, EB | 1 |
| Harris, LF | 1 |
| Le Grand, MP | 1 |
| Serio, RA | 1 |
| Noxon, JO | 1 |
| Digilio, K | 1 |
| Schmidt, DA | 1 |
| Miller, BM | 1 |
| Waterhouse, G | 1 |
| Dean, RH | 1 |
| Smith, BM | 1 |
| Kaben, U | 1 |
| Westphal, HJ | 1 |
| Schütt, C | 1 |
| Skierlo, P | 1 |
| Varkey, B | 1 |
| Drouhet, E | 1 |
| Dupont, B | 2 |
| Slama, TG | 3 |
| Sarosi, GA | 4 |
| Stamm, AM | 1 |
| Pottage, JC | 1 |
| Trenholme, GM | 1 |
| Aronson, IK | 1 |
| Harris, AA | 1 |
| Mabey, DC | 1 |
| Ajdukiewicz, AB | 1 |
| Hay, RJ | 1 |
| Toth, BB | 1 |
| Frame, RR | 1 |
| Sathapatayavongs, B | 1 |
| Batteiger, BE | 1 |
| Wheat, J | 3 |
| Wass, JL | 1 |
| Elliott, GS | 1 |
| Whitney, MS | 1 |
| Reed, WM | 1 |
| Tuite, JF | 1 |
| Restrepo, A | 1 |
| Cano, LE | 1 |
| Tabares, AM | 1 |
| Deutsch, PH | 1 |
| Quintiliani, R | 1 |
| Chinn, H | 1 |
| Chernoff, DN | 1 |
| Migliorati, CA | 1 |
| Silverman, S | 1 |
| Green, TL | 1 |
| Boutros, HH | 1 |
| Van Winckle, RB | 1 |
| Evans, GA | 1 |
| Wasan, SM | 1 |
| Kneale, B | 1 |
| Turton, C | 1 |
| Drew, RH | 1 |
| Hafner, R | 1 |
| Wulfsohn, M | 1 |
| Spencer, P | 1 |
| Squires, K | 1 |
| Powderly, W | 1 |
| Wong, B | 1 |
| Rinaldi, M | 1 |
| Saag, M | 1 |
| Hamill, R | 1 |
| Murphy, R | 1 |
| Connolly-Stringfield, P | 1 |
| Briggs, N | 1 |
| Owens, S | 1 |
| Sharkey-Mathis, PK | 1 |
| Velez, J | 1 |
| Fetchick, R | 1 |
| Eichmann, A | 1 |
| Schär, G | 1 |
| Pitche, P | 1 |
| Dossim, A | 1 |
| Mijiyawa, M | 1 |
| Napo-Koura, G | 1 |
| Tchangaï-Walla, K | 1 |
| Nittayananta, W | 1 |
| Kumplanont, P | 1 |
| Srisintorn, S | 1 |
| Akkayanont, P | 1 |
| Chungpanich, S | 1 |
| Teanpaisan, R | 1 |
| Chareonwatanan, M | 1 |
| Nuntanaranont, T | 1 |
| Smith, MB | 1 |
| Schnadig, VJ | 1 |
| Zaharopoulos, P | 1 |
| Van Hook, C | 1 |
| Mackie, JT | 1 |
| Kaufman, L | 1 |
| Ellis, D | 1 |
| Berenguer Berenguer, J | 1 |
| Scheepers, A | 1 |
| Lemmer, J | 1 |
| Velho, GC | 1 |
| Cabral, JM | 1 |
| Massa, A | 1 |
| Daubenton, JD | 1 |
| Beatty, DW | 1 |
| Care, SB | 1 |
| Lacey, SH | 1 |
| Akpuaka, FC | 1 |
| Gugnani, HC | 1 |
| Iregbulam, LM | 1 |
| Guigay, J | 1 |
| Cuguillière, A | 2 |
| Miltgen, J | 1 |
| Lonjon, T | 1 |
| Jancovici, R | 1 |
| Vaylet, F | 1 |
| Natali, E | 1 |
| Le Vagueresse, R | 1 |
| Bonnet, D | 1 |
| L'Her, P | 1 |
| Capone, D | 1 |
| Wanke, B | 1 |
| Monteiro, PC | 1 |
| Lazéra, MS | 1 |
| de Noronha Andrade, G | 1 |
| do Valle, AC | 1 |
| Moreno, AM | 1 |
| Londero, AT | 1 |
| Odio, CM | 1 |
| Navarrete, M | 1 |
| Carrillo, JM | 1 |
| Mora, L | 1 |
| Carranza, A | 1 |
| Bérard, H | 1 |
| Astoul, P | 1 |
| Frenay, C | 1 |
| Cho, K | 1 |
| Boutin, C | 1 |
| Brooks, JT | 1 |
| Wheat, LJ | 5 |
| Briand, V | 1 |
| Lortholary, O | 1 |
| N'dri Oka, D | 1 |
| Varlet, G | 1 |
| Kakou, M | 1 |
| Zunon-Kipre, Y | 1 |
| Broalet, E | 1 |
| Ba Zeze, V | 1 |
| Nijhawan, M | 1 |
| Nijhawan, S | 1 |
| Vijayvergiya, R | 1 |
| Agarwal, S | 1 |
| Hostetler, JS | 2 |
| Denning, DW | 1 |
| Stevens, DA | 3 |
| Bayles, MA | 2 |
| Schaberg, T | 1 |
| Lode, H | 1 |
| Cloud, GC | 1 |
| Kauffman, CA | 2 |
| Chapman, SW | 1 |
| George, RB | 1 |
| Girard, WM | 1 |
| Saag, MS | 2 |
| Bowles-Patton, C | 1 |
| Navarro, EE | 1 |
| Tupasi, TE | 1 |
| Verallo, VM | 1 |
| Romero, RC | 1 |
| Tuazon, CU | 1 |
| Delclaux, C | 1 |
| Schutz, R | 1 |
| Calzolari, M | 1 |
| Balloul, E | 1 |
| Zango, B | 1 |
| Mathisen, DJ | 1 |
| Grillo, HC | 1 |
| Zainudin, BM | 1 |
| Kassim, F | 1 |
| Annuar, NM | 1 |
| Lim, CS | 1 |
| Ghazali, AK | 1 |
| Murad, Z | 1 |
| Tinelli, M | 1 |
| Michelone, G | 1 |
| Cavanna, C | 1 |
| Kell, PD | 1 |
| Smith, DE | 1 |
| Barton, SE | 1 |
| Midgley, J | 2 |
| Samarasinghe, PL | 1 |
| Gazzard, BG | 1 |
| Sauri, MA | 1 |
| Julie, NL | 1 |
| Juarbe, HM | 1 |
| Mayo, FJ | 1 |
| Ligon, CH | 1 |
| Fox, RL | 1 |
| Koss, G | 1 |
| Coggin, JT | 1 |
| Burbach, JW | 1 |
| Barton, JH | 1 |
| Joshi, N | 1 |
| Hamory, BH | 1 |
| Mello, KA | 1 |
| Lis, R | 1 |
| Donnelly, B | 1 |
| Skolnik, PR | 1 |
| Cohen, PR | 1 |
| Held, JL | 1 |
| Grossman, ME | 1 |
| Ross, MJ | 1 |
| Silvers, DN | 1 |
| Feman, SS | 1 |
| Pritchett, P | 1 |
| Johns, K | 1 |
| Westrich, DJ | 1 |
| Salmon, WD | 1 |
| Fletcher, SM | 1 |
| Prussin, AJ | 1 |
| Youle, M | 1 |
| Nelson, M | 1 |
| Rowe, I | 1 |
| Campbell, C | 1 |
| Gazzard, B | 1 |
| Nightingale, SD | 1 |
| Parks, JM | 1 |
| Pounders, SM | 1 |
| Burns, DK | 1 |
| Reynolds, J | 1 |
| Hernandez, JA | 1 |
| Urschel, HC | 1 |
| Razzuk, MA | 1 |
| Netto, GJ | 1 |
| Disiere, J | 1 |
| Chung, SY | 1 |
| Hiltbrand, JB | 1 |
| McGuirt, WF | 1 |
| Barton, EN | 1 |
| Roberts, L | 1 |
| Ince, WE | 1 |
| Patrick, AL | 1 |
| Suite, M | 1 |
| Basdayemaharaj, K | 1 |
| Jankey, N | 1 |
| Cleghorn, F | 1 |
| Bartholomew, C | 1 |
| Negroni, R | 3 |
| Robles, AM | 1 |
| Arechavala, A | 1 |
| Taborda, A | 1 |
| Finquelievich, JL | 1 |
| Iovannitti, C | 1 |
| Bava, AJ | 1 |
| Martin, RA | 1 |
| Williams, T | 1 |
| Montalto, N | 1 |
| Vanbastelaer, FE | 1 |
| Rawlinson, WD | 1 |
| Packham, DR | 1 |
| Gardner, FJ | 1 |
| MacLeod, C | 1 |
| Ramírez Rivera, J | 1 |
| Johnson, PC | 2 |
| Hamill, RJ | 2 |
| Palmieri, OJ | 1 |
| Chá Torea, JC | 1 |
| Washburn, RG | 1 |
| Bennett, JE | 1 |
| Quinones, CA | 1 |
| Reuben, AG | 1 |
| Musher, DM | 1 |
| Gorin, AB | 1 |
| Palou, E | 1 |
| Ahrens, J | 1 |
| Polak, A | 1 |
| Dixon, DM | 1 |
| Apperloo, AJ | 1 |
| Nelis, GF | 1 |
| Sharma, AK | 1 |
| Dhar, A | 1 |
| Murti, PK | 1 |
| Deshpande, S | 1 |
| Dhar, P | 1 |
| Terpenning, MS | 1 |
| Khardori, N | 1 |
| Najjar, AF | 1 |
| Butt, F | 1 |
| Mansell, PW | 1 |
| Meyer, RD | 1 |
| Flynn, PM | 1 |
| Barrett, FF | 1 |
| Herrod, HG | 1 |
| Dunlap, MD | 1 |
| Goodpasture, HC | 2 |
| Morford, DW | 1 |
| Shadomy, S | 1 |
| Espinel-Ingroff, A | 1 |
| Tartaglione, TA | 1 |
| Mandell, W | 1 |
| Goldberg, DM | 1 |
| Neu, HC | 1 |
| Zeckel, ML | 1 |
| Goetz, MB | 1 |
| Jones, JM | 1 |
| Roudebush, P | 1 |
| Hershberger, RE | 1 |
| Barnett, AM | 1 |
| Peterie, JD | 1 |
| Gustafson, PR | 1 |
| Henson, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study to Determine the Feasibility of Itraconazole for Suppression of Relapse of Disseminated Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome[NCT00000992] | Phase 1 | 30 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
21 reviews available for ketoconazole and Histoplasmosis
| Article | Year |
|---|---|
Pulmonary histoplasmosis presenting with the reversed halo sign on high-resolution CT scan.
Topics: Adult; Animals; Antifungal Agents; Chiroptera; Environmental Exposure; Histoplasmosis; Humans; Ketoc | 2011 |
Nodular pulmonary histoplasmosis in Cushing's disease: a case report and literature review.
Topics: Adenoma; Aminoglutethimide; Dexamethasone; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung | 2007 |
Current management of fungal enteritis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Diarrhea; Enteritis; Histoplasmosis; Humans; Imidazo | 1982 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
Ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Chemical Phenomena; Chemistry; C | 1984 |
Histoplasmosis: recognition and treatment.
Topics: Amphotericin B; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Serologic Tests | 1994 |
Pharmacotherapy of disseminated histoplasmosis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; | 1993 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top | 1995 |
Disseminated histoplasmosis: aspects of oral diagnosis.
Topics: Adult; Antifungal Agents; Biopsy; Diagnosis, Differential; Histoplasma; Histoplasmosis; Humans; Keto | 1992 |
African histoplasmosis: report of two patients treated with amphotericin B and ketoconazole.
Topics: Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Histoplasma; Histoplasmosis; Hu | 1998 |
[Exotic pulmonary mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Bla | 1998 |
[American pulmonary histoplasmosis caused by Histoplasma capsulatum].
Topics: Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Asia; Australia; B | 1998 |
Histoplasmosis in Indianapolis.
Topics: Amphotericin B; Disease Outbreaks; Fluconazole; Histoplasmosis; Humans; Indiana; Itraconazole; Ketoc | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomy | 1992 |
[Generalized histoplasmosis due to Histoplasma duboisii with mediastino-pulmonary infection. Cure after 15 months of treatment with ketoconazole].
Topics: Biopsy; Burkina Faso; Child; Female; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; Me | 1992 |
Oropharyngeal histoplasmosis.
Topics: Adult; Amphotericin B; Child; Chronic Disease; Diagnosis, Differential; Histoplasmosis; Humans; Infa | 1990 |
Diagnosis and management of histoplasmosis.
Topics: Amphotericin B; Histoplasma; Histoplasmosis; Humans; Immune Tolerance; Ketoconazole; Time Factors; U | 1989 |
Treatment of histoplasmosis and blastomycosis.
Topics: Amphotericin B; Blastomycosis; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal | 1988 |
Deep fungal infections in the elderly.
Topics: Age Factors; Aged; Amphotericin B; Blastomycosis; Coccidioidomycosis; Histoplasmosis; Humans; Ketoco | 1988 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
Mycotic pneumonias.
Topics: Amphotericin B; Animals; Aspergillosis; Blastomycosis; Cat Diseases; Cats; Coccidioidomycosis; Crypt | 1985 |
5 trials available for ketoconazole and Histoplasmosis
| Article | Year |
|---|---|
Oral antifungal agent effective even for widespread infections.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topi | 1980 |
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigen | 1993 |
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Blastomycosis; Female; Histoplasmosis; Humans; It | 1992 |
Itraconazole in human histoplasmosis.
Topics: Adult; Aged; Antifungal Agents; Clinical Trials as Topic; Female; Histoplasmosis; Humans; Itraconazo | 1989 |
Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Topics: Adult; Aged; Blastomycosis; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, D | 1985 |
87 other studies available for ketoconazole and Histoplasmosis
| Article | Year |
|---|---|
Histoplasmosis with draining lymphadenopathy.
Topics: Histoplasmosis; Humans; Ketoconazole; Lymphatic Diseases; Male; Middle Aged | 1984 |
[A case of disseminated histoplasmosis treated with ketoconazole in Panama].
Topics: Adult; Histoplasmosis; Humans; Ketoconazole; Male | 1984 |
Hematogenous histoplasmosis in the immunocompromised child.
Topics: Adolescent; Amphotericin B; Antineoplastic Agents; Child; Child, Preschool; Female; Histoplasmosis; | 1984 |
Disseminated histoplasmosis in patients with the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Histoplasmosis; Humans; Immunity, Cellular; Ketoconazole; | 1984 |
Ketoconazole treatment of chronic mucocutaneous candidiasis.
Topics: Adolescent; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Cryptococcosi | 1980 |
[Oral ketoconazole therapy of a case of pulmonary histoplasmosis].
Topics: Administration, Oral; Dose-Response Relationship, Drug; Histoplasmosis; Humans; Imidazoles; Ketocona | 1981 |
Progressive disseminated histoplasmosis; favorable response to ketoconazole.
Topics: Alkaline Phosphatase; Antifungal Agents; Body Weight; Dose-Response Relationship, Drug; Histoplasmos | 1981 |
Conditions associated with relapse of amphotericin B-treated disseminated histoplasmosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Endocarditis; Histoplasmosis; Humans; Imidazoles; Ketoconaz | 1982 |
Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens.
Topics: Adolescent; Adult; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Adm | 1982 |
Histoplasmosis in Huntsville, Alabama.
Topics: Acute Disease; Adolescent; Adult; Aged; Alabama; Amphotericin B; Bone Diseases; Chronic Disease; His | 1982 |
Disseminated histoplasmosis in a cat: successful treatment with ketoconazole.
Topics: Administration, Oral; Animals; Antifungal Agents; Cat Diseases; Cats; Female; Histoplasma; Histoplas | 1982 |
Histoplasma infection of abdominal aortic aneurysms.
Topics: Adult; Aged; Amphotericin B; Aorta, Abdominal; Aortic Aneurysm; Arteriosclerosis; Female; Histoplasm | 1983 |
[African histoplasmosis; immunological parameters and treatment with ketoconazole].
Topics: Adult; Antifungal Agents; Histoplasmosis; Humans; Imidazoles; Immunity, Cellular; Ketoconazole; Male | 1982 |
Oral antifungal therapy. Current status of ketoconazole.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Coccidioidomycosis; Histoplasmosis; Humans; Im | 1983 |
Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.
Topics: Adolescent; Adult; Antifungal Agents; Arthritis, Infectious; Blastomycosis; Candidiasis; Candidiasis | 1983 |
Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole.
Topics: Adult; Aged; Antifungal Agents; Disease Outbreaks; Drug Evaluation; Female; Histoplasmosis; Humans; | 1983 |
Management of fungal diseases.
Topics: Blastomycosis; Coccidioidomycosis; Complement Fixation Tests; Histoplasmosis; Humans; Imidazoles; Ke | 1983 |
Panniculitis associated with histoplasmosis and alpha 1-antitrypsin deficiency.
Topics: Adult; alpha 1-Antitrypsin Deficiency; Histoplasmosis; Humans; Imidazoles; Ketoconazole; Male; Panni | 1983 |
Treatment of African histoplasmosis with ketoconazole.
Topics: Child, Preschool; Female; Histoplasmosis; Humans; Imidazoles; Ketoconazole; Piperazines | 1983 |
Oral histoplasmosis: diagnostic complication and treatment.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; Diagnosis, Differential; Histoplasmosis; Humans; Imidaz | 1983 |
Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Disease Outbreaks; Histoplasmosis; | 1983 |
Antemortem diagnosis of paecilomycosis in a cat.
Topics: Animals; Cat Diseases; Cats; Female; Granuloma; Histoplasmosis; Ketoconazole; Mitosporic Fungi; Myco | 1984 |
A comparison of mycelial filtrate - and yeast lysate - paracoccidioidin in patients with paracoccidioidomycosis.
Topics: Adult; Antigens, Fungal; Coccidioidin; Female; Fungal Proteins; Histoplasmosis; Humans; Ketoconazole | 1983 |
Oral histoplasmosis in HIV-infected patients. A report of two cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Histoplasmosis; HIV Infections; Humans | 1995 |
Oral histoplasmosis masquerading as an invasive carcinoma.
Topics: Aged; Amphotericin B; Chronic Disease; Diagnosis, Differential; Female; Histoplasmosis; Humans; Keto | 1995 |
Bronchoscopic findings in a case of bronchopulmonary histoplasmosis.
Topics: Amphotericin B; Biopsy; Bronchoscopy; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; M | 1995 |
Itraconazole.
Topics: Antifungal Agents; Blastomycosis; Drug Interactions; Histoplasmosis; Humans; Itraconazole; Ketoconaz | 1993 |
Itraconazole released for blastomycosis and histoplasmosis therapy.
Topics: Antifungal Agents; Blastomycosis; Drug Approval; Drug Therapy, Combination; Histoplasmosis; Humans; | 1993 |
Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; His | 1993 |
[African histoplasmosis in a patient with HIV-2 infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1996 |
[Multiple bone lesions of a type of disseminated African histoplasmosis in a Togolese immunocompetent child].
Topics: Acromion; Amphotericin B; Antifungal Agents; Child; Clavicle; Histoplasmosis; Humans; Immunocompeten | 1995 |
Oral histoplasmosis associated with candidiasis in HIV-infected patients: a report of two cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Female; Histopla | 1997 |
Disseminated Histoplasma capsulatum infection presenting as genital ulcerations.
Topics: Antifungal Agents; Chronic Disease; Female; Histoplasmosis; Humans; Ketoconazole; Middle Aged; Papan | 1997 |
Confirmed histoplasmosis in an Australian dog.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Histoplasma; Histoplasmosis; Ketocon | 1997 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
African histoplasmosis: therapeutic efficacy of itraconazole.
Topics: Antifungal Agents; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1998 |
Disseminated histoplasmosis in an 'immunocompetent' child.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Child; Histoplasma; Histoplasmosis; Humans | 1998 |
Recurrent histoplasmosis of the wrist: a case report.
Topics: Adult; Antifungal Agents; Carpal Tunnel Syndrome; Histoplasmosis; Humans; Itraconazole; Ketoconazole | 1998 |
Chronic pulmonary histoplasmosis in the State of Rio de Janeiro, Brazil.
Topics: Aged; Amphotericin B; Antifungal Agents; Brazil; Fatal Outcome; Female; Histoplasma; Histoplasmosis; | 1999 |
Disseminated histoplasmosis in infants.
Topics: Amphotericin B; Antifungal Agents; Costa Rica; Endemic Diseases; Female; Histoplasmosis; Humans; Inf | 1999 |
[Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection].
Topics: Antifungal Agents; Brain; Brain Diseases; Central Nervous System Fungal Infections; Fluconazole; His | 1999 |
Histoplasmosis: update 1998.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Dis | 1998 |
[Endemic mycotic infections].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Cocc | 2001 |
[Spondylodiscitis due to Histoplasma duboisii. Report of two cases and review of the literature].
Topics: Abscess; Adult; Antifungal Agents; Discitis; Female; Histoplasma; Histoplasmosis; Humans; Ketoconazo | 2001 |
Oral histoplasmosis.
Topics: Aged; Biopsy, Needle; Disease Progression; Fatal Outcome; Fungemia; Histoplasmosis; Humans; India; K | 2001 |
US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchop | 1992 |
Tropical mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Femal | 1992 |
Disseminated histoplasmosis with unusual cutaneous lesions in a patient from the Philippines.
Topics: Amphotericin B; Dermatomycoses; Female; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; | 1992 |
Clinical manifestation of mediastinal fibrosis and histoplasmosis.
Topics: Adolescent; Adult; Amphotericin B; Boston; Combined Modality Therapy; Esophagoplasty; Female; Fibros | 1992 |
Disseminated histoplasmosis presenting with ileal perforation in a renal transplant recipient.
Topics: Adult; Amphotericin B; Diagnosis, Differential; Female; Histoplasmosis; Humans; Ileal Diseases; Inte | 1992 |
Recurrent Histoplasma capsulatum pneumonia: a case report.
Topics: Adult; Amphotericin B; Dust; Histoplasmosis; Humans; Ketoconazole; Male; Occupational Diseases; Pneu | 1992 |
Disseminated histoplasmosis in an AIDS patient treated with itraconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Blood; Histoplasma; Histoplasmosis; Hu | 1991 |
[Tropical mycoses].
Topics: Antifungal Agents; Blastomycosis; Chromoblastomycosis; Clinical Trials as Topic; Female; Histoplasmo | 1991 |
[The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Cry | 1991 |
Disseminated histoplasmosis in AIDS patients in Maryland.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Female; Histoplasma; Histoplasmosis | 1991 |
Drug-resistant Nocardia asteroides infection in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Drug Resistance, Microbial; Histoplasmosi | 1991 |
Ketoconazole-responsive tonsillar infection due to Histoplasma capsulatum in an HIV-1-seropositive individual.
Topics: Histoplasmosis; HIV Seropositivity; Humans; Ketoconazole; Male; Middle Aged; Tonsillitis | 1991 |
Disseminated histoplasmosis presenting as an ulcerated verrucous plaque in a human immunodeficiency virus-infected man. Report of a case possibly involving human-to-human transmission of histoplasmosis.
Topics: Dermatomycoses; Histoplasmosis; HIV Infections; Humans; Ketoconazole; Lip; Male; Middle Aged | 1991 |
Intraocular tumor from disseminated histoplasmosis.
Topics: Amphotericin B; Eye Neoplasms; Histoplasmosis; Humans; Ketoconazole; Male; Middle Aged; Visual Acuit | 1991 |
Histoplasmosis of the larynx treated with ketoconazole: a case report.
Topics: Chronic Disease; Histoplasmosis; Humans; Ketoconazole; Laryngeal Diseases; Laryngoscopy; Male; Middl | 1990 |
Histoplasmosis in a UK patient treated with itraconazole.
Topics: Adult; Histoplasmosis; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; United Kingdom | 1990 |
Disseminated histoplasmosis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Actuarial Analysis; Adult; Amphotericin B; Cryptococcosis; Evalu | 1990 |
Sclerosing mediastinitis: improved management with histoplasmosis titer and ketoconazole.
Topics: Adult; Complement Fixation Tests; Female; Histoplasmosis; Humans; Ketoconazole; Male; Mediastinitis; | 1990 |
Cutaneous histoplasmosis in the acquired immune deficiency syndrome--a report of three cases from Trinidad.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Biopsy; Dermatomycoses; Enzyme-Linked Imm | 1988 |
Treatment of disseminated histoplasmosis in hamsters.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Cricetinae; Female; Histoplasma | 1989 |
AIDS with disseminated histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Histoplasmosis; Humans; Ketoconazole; Mal | 1989 |
Chest mass in an 11-year-old.
Topics: Child; Histoplasma; Histoplasmosis; Humans; Ketoconazole; Male | 1989 |
Histoplasmosis in the acquired immunodeficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Histoplasmosis; Humans; Ketoconazole; Lymph Nodes; Male; Middle | 1989 |
Acute histoplasmosis: a modern appraisal.
Topics: Acute Disease; Adult; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Puerto Rico | 1989 |
Clinical review: progressive disseminated histoplasmosis in the AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Biopsy; Histoplasma; Histoplasmosis; Humans; Ket | 1989 |
[Treatment of paracoccidioidomycosis and histoplasmosis by oral itraconazole].
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Histoplasmosis; Humans; Itraconazole; Ketocona | 1987 |
Reversal of adrenal glucocorticoid dysfunction in a patient with disseminated histoplasmosis.
Topics: Adrenal Cortex Diseases; Female; Histoplasmosis; Humans; Hydrocortisone; Ketoconazole; Middle Aged; | 1989 |
Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole.
Topics: Administration, Oral; Amphotericin B; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; M | 1989 |
Treatment of murine histoplasmosis with UK 49,858 (fluconazole).
Topics: Animals; Antifungal Agents; Female; Fluconazole; Histoplasmosis; Ketoconazole; Lung Diseases, Fungal | 1986 |
Fungistatic and fungicidal effects of amphotericin B, ketoconazole and fluconazole (UK 49,858) against histoplasma capsulatum in vitro and in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Culture Techniques; Fluconazole; Histoplasma; Histoplasm | 1987 |
Asian form of disseminated histoplasmosis diagnosed by CT-guided biopsy of the adrenals treated with ketoconazol.
Topics: Adrenal Glands; Aged; Amphotericin B; Biopsy; Histoplasmosis; Humans; Indonesia; Ketoconazole; Male; | 1988 |
A case of disseminated histoplasmosis treated successfully with ketoconazole.
Topics: Adult; Histoplasmosis; Humans; Ketoconazole; Male | 1988 |
Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Female; Histoplasmosis; Humans; Ketoconaz | 1988 |
Disseminated histoplasmosis in two patients with chronic mucocutaneous candidiasis.
Topics: Adult; Amphotericin B; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Female; Histoplasmosi | 1987 |
Histoplasmosis therapy.
Topics: Amphotericin B; Child; Histoplasmosis; Humans; Ketoconazole; Male | 1986 |
Disseminated histoplasmosis in dialysis patients.
Topics: Histoplasmosis; Humans; Ketoconazole; Peritoneal Dialysis, Continuous Ambulatory | 1986 |
Treatment of systemic mycoses with ketoconazole: studies of ketoconazole serum levels.
Topics: Blastomycosis; Child, Preschool; Coccidioidomycosis; Cryptococcosis; Histoplasmosis; Humans; Ketocon | 1986 |
Histoplasmosis in patients with the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Drug Therapy, Combination; Ethnicity; Fem | 1986 |
Histoplasmosis in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis; Female; Herpes Simplex; Hist | 1985 |
Combined ketoconazole and amphotericin B treatment of acute disseminated histoplasmosis in a renal allograft recipient.
Topics: Acute Disease; Adult; Amphotericin B; Drug Combinations; Follow-Up Studies; Histoplasmosis; Humans; | 1985 |
Treatment of central nervous system fungal infection with ketoconazole.
Topics: Aged; Coccidioidomycosis; Drug Administration Schedule; Encephalitis; Female; Histoplasmosis; Humans | 1985 |
Ketoconazole therapy for AIDS patients with disseminated histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Histoplasmosis; Humans; Ketoconazole; Male; Recurrence | 1985 |